Back to search

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled MR-monitored phase II trial

Data up to Jan 2025

Published1997
Citations261
References13
Clinical Trials (1)

Total Citations Per Year

Abstract

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of… (1997) – Neurology | Metascience Observatory Explorer